Processa Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. 

CEO
George K. Ng
CEOGeorge K. Ng
Employees
10
Employees10
Headquarters
Hanover, Maryland
HeadquartersHanover, Maryland
Founded
2011
Founded2011
Employees
10
Employees10

PCSA Key Statistics

Market cap
7.57M
Market cap7.57M
Price-Earnings ratio
-0.09
Price-Earnings ratio-0.09
Dividend yield
Dividend yield
Average volume
82.89M
Average volume82.89M
High today
$0.298
High today$0.298
Low today
$0.2656
Low today$0.2656
Open price
$0.27
Open price$0.27
Volume
12.65M
Volume12.65M
52 Week high
$3.10
52 Week high$3.10
52 Week low
$0.15
52 Week low$0.15

People also own

Based on the portfolios of people who own PCSA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.